摘要
目的探讨强化抗结核药物治疗初治活动性肺结核的临床效果。方法选取我院2010年11月-2015年11月收治的90例初治活动性肺结核患者,分为研究组和对照组,每组45例,对照组采用抗结核固定复合制剂（FDC）治疗,研究组采用异烟肼、利福平、吡嗪酰胺、乙胺丁醇四联为基础的强化抗结核治疗,分析两组抗结核药物的治疗效果。结果研究组总有效率为95.55%,对照组为93.33%,两组比较差异无统计学意义（P〉0.05）。结论抗结核固定复合制剂与强化抗结核治疗初治活动性肺结核的临床效果相当,均可改善患者的病情。
Objective To explore the effect of anti-tuberculosis drugs in the treatment of the early active tuberculosis. Methods From November 2010 to November 2015,90 cases of patients with active tuberculosis were selected,they were divided into research group and the control group,45 cases in each group. Control group was treated by anti-tuberculosis fixed compound preparation（FDC）,research group was given intensive anti-tuberculosis treatment with isoniazid,rifampicin,pyrazinamide and ethambutol,then the therapeutic effect of two groups was analyzed. Results The total effective rate of treatment group was 95.55%,control group was 93.33%,the difference between the two groups has no statistical significance（P〈0.05）. Conclusion The clinical effect of patients with active tuberculosis who treated by anti-tuberculosis fixed compound preparation and intensive antituberculosis show quite, and all can improve the patient＇s condition.
出处
《中国卫生标准管理》
2016年第20期141-142,共2页
China Health Standard Management
关键词
初治活动性肺结核
强化抗结核
疗效
Primary active pulmonary tuberculosis
Enhanced anti tuberculosis
Effect
